Jacobs Levy Equity Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Jacobs Levy Equity Management’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-48,163	Closed	-$2.87M	–	1136
2021 Q3	$2.87M	Buy	48,163 +30,992	+180%	+$1.83M	0.02%	542
2021 Q2	$1.17M	Buy	+17,171	New	+$1.12M	0.01%	712
2017 Q2	–	Sell	-19,590	Closed	-$286K	–	1041
2017 Q1	$286K	Buy	+19,590	New	+$290K	0.01%	734
2016 Q3	–	Sell	-10,414	Closed	-$178K	–	1172
2016 Q2	$178K	Buy	+10,414	New	+$186K	﹤0.01%	1028

Other funds holding ARNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jacobs Levy Equity Management's ARNA Position: Q4 2021 in Review

Jacobs Levy Equity Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2021, closing a stake of 48,163 shares — an estimated $2.87M sold.

Jacobs Levy Equity Management first reported a position in ARNA in Q2 2016 and held it in 4 quarters. The position peaked at $2.87M in Q3 2021. 317 funds tracked by Wall St. Rank hold ARNA as of Q4 2021.

Jacobs Levy Equity Management reported no remaining Arena Pharmaceuticals Inc position as of Q4 2021 after selling out during the quarter.
Jacobs Levy Equity Management sold 48,163 Arena Pharmaceuticals Inc shares in Q4 2021, an estimated $2.87M.
Jacobs Levy Equity Management first reported a position in Arena Pharmaceuticals Inc in Q2 2016 and held it in 4 quarters.
Jacobs Levy Equity Management's Arena Pharmaceuticals Inc position peaked at $2.87M in Q3 2021.
317 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.